← All trials
NCT01478035
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2011
- Primary completion
- Dec 1, 2013
- Completion date
- Mar 1, 2014
- First posted
- —
- Last posted
- —
- Enrollment
- 122
- Arms / groups
- 2 / —
- Source
- AACT · pre-existing
Sponsors
- Hospital Universitari de BellvitgeLead sponsor
- Hospital Mutua de TerrassaCollaborator
- University of SevilleCollaborator
- University of BarcelonaSponsor investigator
- University of BarcelonaCollaborator
- Hospital Juan CanalejoCollaborator
- Hospital Universitario Virgen MacarenaCollaborator
- University of BarcelonaOverall official - principal investigator
- Universidad Complutense de MadridCollaborator
- Universidad Autonoma de MadridCollaborator
- Badalona Hospital Germans Trias i PujolCollaborator
- Universidad Autonoma de BarcelonaCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.